Unknown PHASE4 INTERVENTIONAL NCT00265772

Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis

Phase IV Study Comparing a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis

Sponsor: Hôpital Necker-Enfants Malades

Conditions Crohn's Disease Pediatric

Interventions MODULEN IBD (R) (specific Enteral Nutrition) prednisolon

Updated 5 times since 2017 Last updated: Dec 14, 2005 Started: Nov 30, 2005 Completion: Apr 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00265772, this PHASE4 trial focuses on Crohn's Disease and Pediatric and remains ongoing. Sponsored by Hôpital Necker-Enfants Malades, it has been updated 5 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Mar 2023 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2021 — Mar 2023 [monthly]

Unknown Status PHASE4
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE4

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hôpital Necker-Enfants Malades
Institut National de la Santé Et de la Recherche Médicale, France
Société des Produits Nestlé (SPN)

Data source: Hôpital Necker-Enfants Malades

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France